ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 527 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Adding More Mushrooms to Your Diet May Decrease Your Risk of... April 21, 2021 On legacy giving: “It allows me to give something more meaningful... October 13, 2021 Baby Boy Can’t Stop Smiling After Surgery Allows Him To See... September 18, 2019 EMA Recommends Granting a Marketing Authorisation for Azacitidine May 3, 2021 Load more HOT NEWS Pralsetinib: Measures to Minimise Increased Risk for Tuberculosis A Single Colonoscopy Reduces CRC Risk, but Not CRC Mortality Commemorating the Contributions of Cancer Research Greats Soaring skin cancer cases hit a record high
